Trials / Unknown
UnknownNCT02862483
The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- Male
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy and safety of the combination of tamsulosin and tadalafil in men with lower urinary tract symptoms due to benign prostatic hyperplasia and Erectile Dysfunction: a randomized, double blinded, parallel design, active controlled, multi-center, phase 3 clinical trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin 0.2mg | |
| DRUG | Tadalafil 5mg | |
| DRUG | Placebo for Tamsulosin |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2016-08-11
- Last updated
- 2016-08-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02862483. Inclusion in this directory is not an endorsement.